These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28288256)

  • 21. New drugs in development targeted to women's health.
    Meisler JG
    J Womens Health; 1998 Feb; 7(1):93-117. PubMed ID: 9511137
    [No Abstract]   [Full Text] [Related]  

  • 22. Trials and tribulations: including women in cancer clinical research.
    Tang C; Hamad N
    Lancet Haematol; 2021 Jul; 8(7):e477-e478. PubMed ID: 34171277
    [No Abstract]   [Full Text] [Related]  

  • 23. The industry perspective on the inclusion of women in clinical trials.
    Bush JK
    Acad Med; 1994 Sep; 69(9):708-15. PubMed ID: 8074760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does exclusion or inclusion better protect women?
    Shultz MM
    J Gend Specif Med; 1998; 1(2):18-22. PubMed ID: 11281007
    [No Abstract]   [Full Text] [Related]  

  • 25. Advances in cardiovascular pharmacology: protocol design and methodology--the US regulatory process.
    Somberg JC; Borer JS
    Am J Ther; 1999 May; 6(3):175-8. PubMed ID: 10423661
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of worldwide clinical trials by gender: An FDA perspective.
    Ayuso E; Geller RJ; Wang J; Whyte J; Jenkins M
    Contemp Clin Trials; 2019 May; 80():16-21. PubMed ID: 30890465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in cardiovascular pharmacology.
    Hayes AH
    JAMA; 1982 Aug; 248(5):537-43. PubMed ID: 7097893
    [No Abstract]   [Full Text] [Related]  

  • 28. Office of Women's Health, Food and Drug Administration: future directions for women's health.
    Wood SF
    J Am Med Womens Assoc (1972); 2001; 56(4):197-8. PubMed ID: 11759792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute.
    Harris DJ; Douglas PS
    N Engl J Med; 2000 Aug; 343(7):475-80. PubMed ID: 10944565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The US Food and Drug Administration Cardiorenal Advisory Panel and the drug approval process.
    Roden DM; Temple R
    Circulation; 2005 Apr; 111(13):1697-702. PubMed ID: 15811869
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiovascular biomarkers and surrogate end points: key initiatives and clinical trial challenges.
    Heinonen TM; Aamer M; Marshall C; Black DM; Tardif JC
    Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):989-94. PubMed ID: 23030288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women abound in NIH trials.
    Holden C
    Science; 2008 Oct; 322(5899):219. PubMed ID: 18845746
    [No Abstract]   [Full Text] [Related]  

  • 33. Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.
    Wissing MD; Kluetz PG; Ning YM; Bull J; Merenda C; Murgo AJ; Pazdur R
    Cancer; 2014 Oct; 120(19):3025-32. PubMed ID: 24965506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming Drug Development in Heart Failure: Navigating the Regulatory Crossroads.
    Vaduganathan M; Butler J; Gheorghiade M
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27707750
    [No Abstract]   [Full Text] [Related]  

  • 35. US Food and Drug Administration Office of Women's Health: Promoting Therapeutic Optimization in Women.
    South EM; Zinn RL; Huang CJ; Vasisht KP
    J Clin Pharmacol; 2020 Dec; 60 Suppl 2():S11-S17. PubMed ID: 33274515
    [No Abstract]   [Full Text] [Related]  

  • 36. Improving the Safety and Effectiveness of Medical Device Therapy in Women.
    Zusterzeel R; O'Callaghan KM; Caños DA; Sanders WE; Marinac-Dabic D; Strauss DG
    J Womens Health (Larchmt); 2016 May; 25(5):428-30. PubMed ID: 27028582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of analysis by gender in the Cochrane reviews as related to treatment of cardiovascular disease.
    Johnson SM; Karvonen CA; Phelps CL; Nader S; Sanborn BM
    J Womens Health (Larchmt); 2003 Jun; 12(5):449-57. PubMed ID: 12869292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving women's health through modernization of our bioinformatics infrastructure.
    Oliva A; Pinnow E; Levin R; Uhl K
    Clin Pharmacol Ther; 2008 Jan; 83(1):192-5. PubMed ID: 17987048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. US Food and Drug Administration office of women's health: update.
    Sheppard A
    J Am Med Womens Assoc (1972); 1999; 54(2):97-8. PubMed ID: 10319599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDA Drug Trials Snapshots-A Clearer Picture.
    Dhruva SS; Redberg RF
    JAMA Intern Med; 2017 May; 177(5):727. PubMed ID: 28288250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.